News & updates

LUMC talent Edouard Fu receives NWO Rubicon grant to conduct research at Harvard Medical School

Created on:


October 6, 2021

Edouard Fu, PhD student at the Department of Clinical Epidemiology at the LUMC, uses big data to study the effectiveness and safety of kidney, diabetes and heart failure treatments. With a Rubicon grant from NWO, Edouard will conduct further research at Harvard Medical School over the next two years.

In the first round of Rubicon 2021, a total of 24 newly graduated scientists were selected to conduct research abroad at prestigious institutions such as Oxford and Harvard. 

Wonder drugs for diabetics?

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new group of medications used for treating patients with type 2 diabetes, kidney disease, or heart failure. The potential impact of this novel medication class is enormous: type 2 diabetes currently affects more than 400 million people worldwide, whereas heart failure is the leading cause of hospitalizations in the Western world. 

Considered a breakthrough in the treatment of diabetes and heart failure, Edouard Fu – however – highlights that initial clinical trials on the effectiveness and safety of SGLT2 inhibitors do not portray the whole picture quite yet. “These trials included very selective patient populations and their study size and duration is often not sufficient to investigate rare – but potentially serious safety outcomes. By applying cutting-edge statistical methods to big data of more than 200 million patients, we will be able to investigate the effectiveness and safety of these drugs in patients with diabetes and heart failure in a real-life setting.” 

Read the full article here.


More news & updates

Successful return of international students at the LUMC during the first semester

March 9, 2022

Long have we awaited the moment that we could welcome international students at the LUMC again. Due to COVID, all student mobility was cancelled for over 1,5 years. And despite still having regulations in place, especially during the first semester of the academic year 2021-2022, it was refreshing to cautiously welcome international students again. We’re so pleased to see that the students who came to Leiden had a fun, meaningful and above all, educational experience. In a questionnaire, they’ve given us an insight into how they experienced student mobility during these strange times.

Prestigious EJP RD ERN Research Mobility Fellowship awarded to Eva Coopmans and Oana Danila

July 6, 2021

Twice a year, the Research Mobility Fellowships of the European Joint Programme on Rare Diseases (EJP RD) from the European Reference Networks (ERN) get awarded to prominent researchers or MDs to develop new skills and expertise in a European institution specialized in research on rare diseases.

After movie of the Global Impact in Health Symposium is live!

July 21, 2022

On May 30th, international experts and politicians gathered in Leiden to discuss global health issues during the Global Impact in Health Symposium. Lively discussions were held on matters concerning equal worldwide access to vaccines and diversity within clinical research. New scientific insights were also shared, including on vaccine response differences between African and European populations. Missed the event? Check out the after movie and get in touch!

Stay up to date with news, inspirations and events.

© LUMC Global. All rights reserved. Website door philogirl

Contact

Social